The Oncology Institute's Upcoming Q3 Financial Results Call, 2025
Upcoming Earnings Release and Conference Call
The Oncology Institute, Inc. (NASDAQ: TOI), recognized for its commitment to value-based community oncology care, will share its financial results for the third quarter of 2025 after market close on a Thursday in mid-November. Directly after this announcement, a pivotal conference call is scheduled to take place at 5:00 p.m. Eastern Time on the same day. Investors and stakeholders are encouraged to tune in to hear about the company's performance and strategic developments.
How to Access the Conference Call
The upcoming conference call can be accessed live via phone with US-based callers dialing 1-877-407-0789. International callers can join the call by calling 1-201-689-8562. For those who aren't able to join live, a replay will be available about two hours after the call by using the number 1-844-512-2921 for US callers or 1-412-317-6671 for international callers. The passcode for both the live call and replay is 13756737, with replay services accessible until a week later.
Webcast for Interested Investors
For those interested in a digital format, a simultaneous webcast of the conference call will be made available on the company's official website in the Investor Relations section. Logging onto the site will provide valuable insights into the financial results and future directions of The Oncology Institute.
Understanding The Oncology Institute
Founded in 2007, The Oncology Institute (NASDAQ: TOI) is pioneering advancements in oncology through its focus on specialized, value-oriented cancer care offered in community settings. The organization serves approximately 1.9 million patients through innovative care delivery models that encompass clinical trials and transfusion services, traditionally reserved for the most advanced care facilities. The company has expanded to include over 180 employed and affiliate clinicians, spanning more than 100 clinics across five states, thus facilitating improved accessibility and outcomes in cancer treatment.
Company Contacts for Further Inquiries
Individuals seeking more information can reach out to The Oncology Institute directly. Media inquiries can be sent via email to marketing@theoncologyinstitute.com. For investor relations, interested parties can connect through TOI@icrhealthcare.com.
Frequently Asked Questions
1. When is The Oncology Institute's Q3 earnings release?
The earnings release is scheduled for mid-November, after the market closes.
2. How can I participate in the conference call?
You can join by dialing the specified phone numbers for your region or by accessing the webcast on the website.
3. Who should I contact for media inquiries?
For media questions, you can email the company's marketing department.
4. What services does The Oncology Institute provide?
The Oncology Institute offers specialized cancer care, including clinical trials and transfusion services, catering to a diverse patient population.
5. How many clinics does The Oncology Institute operate?
The company operates over 100 clinics and affiliate locations across five states, focusing on community-based cancer care.
About The Author
Contact Thomas Cooper privately here. Or send an email with ATTN: Thomas Cooper as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
